Search research articles
Contact Us
Filters
Showing results (551-560 of 573) with videos related to
Page
of 58
Sort By:
AIDS (London, England)
|
April 7, 2007
Efficacy and safety of etravirine (TMC125) in patients with highly resistant HIV-1: primary 24-week analysis
, Jeffrey P Nadler, Daniel S Berger, et al.
The Lancet. Oncology
|
February 1, 2024
Multiplex analysis of intratumoural immune infiltrate and prognosis in patients with stage II-III colorectal cancer from the SCOT and QUASAR 2 trials: a retrospective analysis
Anja L Frei, Anthony McGuigan, Ritik R A K Sinha, et al.
The Journal of Pathology. Clinical Research
|
September 12, 2023
Accounting for intensity variation in image analysis of large-scale multiplexed clinical trial datasets
Anja L Frei, Anthony McGuigan, Ritik Rak Sinha, et al.
The Lancet. Gastroenterology & Hepatology
|
September 4, 2019
Aspirin as an adjuvant treatment for cancer: feasibility results from the Add-Aspirin randomised trial
Nalinie Joharatnam-Hogan, Fay Cafferty, Richard Hubner, et al.
Journal of Clinical Oncology : Official Journal of the American Society of Clinical Oncology
|
March 28, 2024
Oxaliplatin-Based Adjuvant Chemotherapy in Older Patients With Stage III Colon Cancer: An ACCENT/IDEA Pooled Analysis of 12 Trials
Claire Gallois, Qian Shi, Levi D Pederson, et al.
The Lancet. Oncology
|
March 30, 2019
Capecitabine compared with observation in resected biliary tract cancer (BILCAP): a randomised, controlled, multicentre, phase 3 study
John N Primrose, Richard P Fox, Daniel H Palmer, et al.
The Lancet. Oncology
|
June 24, 2014
Gemcitabine and capecitabine with or without telomerase peptide vaccine GV1001 in patients with locally advanced or metastatic pancreatic cancer (TeloVac): an open-label, randomised, phase 3 trial
Gary Middleton, Paul Silcocks, Trevor Cox, et al.
The Lancet. Psychiatry
|
April 13, 2025
Recommendations for defining treatment outcomes in major psychiatric disorders using real-world data
Elise Koch, Sophie Smart, Guðmundur Einarsson, et al.
Journal of Clinical Oncology : Official Journal of the American Society of Clinical Oncology
|
January 9, 2026
Three Versus 6 Months of Adjuvant Oxaliplatin-Fluoropyrimidine Chemotherapy for Colorectal Cancer: Final Results of SCOT-An International, Randomized, Phase III, Noninferiority Trial
Timothy Iveson, Mark P Saunders, Caroline Kelly, et al.
JAMA Surgery
|
June 12, 2024
Time From Colorectal Cancer Surgery to Adjuvant Chemotherapy: Post Hoc Analysis of the SCOT Randomized Clinical Trial
Mikail Gögenur, Andreas Weinberger Rosen, Timothy Iveson, et al.
Page
of 58
Search research articles
Search
Showing results (551-560 of 573) with videos related to
Sort By:
Page
of 58
AIDS (London, England)
|
April 7, 2007
Efficacy and safety of etravirine (TMC125) in patients with highly resistant HIV-1: primary 24-week analysis
, Jeffrey P Nadler, Daniel S Berger, et al.
The Lancet. Oncology
|
February 1, 2024
Multiplex analysis of intratumoural immune infiltrate and prognosis in patients with stage II-III colorectal cancer from the SCOT and QUASAR 2 trials: a retrospective analysis
Anja L Frei, Anthony McGuigan, Ritik R A K Sinha, et al.
The Journal of Pathology. Clinical Research
|
September 12, 2023
Accounting for intensity variation in image analysis of large-scale multiplexed clinical trial datasets
Anja L Frei, Anthony McGuigan, Ritik Rak Sinha, et al.
The Lancet. Gastroenterology & Hepatology
|
September 4, 2019
Aspirin as an adjuvant treatment for cancer: feasibility results from the Add-Aspirin randomised trial
Nalinie Joharatnam-Hogan, Fay Cafferty, Richard Hubner, et al.
Journal of Clinical Oncology : Official Journal of the American Society of Clinical Oncology
|
March 28, 2024
Oxaliplatin-Based Adjuvant Chemotherapy in Older Patients With Stage III Colon Cancer: An ACCENT/IDEA Pooled Analysis of 12 Trials
Claire Gallois, Qian Shi, Levi D Pederson, et al.
The Lancet. Oncology
|
March 30, 2019
Capecitabine compared with observation in resected biliary tract cancer (BILCAP): a randomised, controlled, multicentre, phase 3 study
John N Primrose, Richard P Fox, Daniel H Palmer, et al.
The Lancet. Oncology
|
June 24, 2014
Gemcitabine and capecitabine with or without telomerase peptide vaccine GV1001 in patients with locally advanced or metastatic pancreatic cancer (TeloVac): an open-label, randomised, phase 3 trial
Gary Middleton, Paul Silcocks, Trevor Cox, et al.
The Lancet. Psychiatry
|
April 13, 2025
Recommendations for defining treatment outcomes in major psychiatric disorders using real-world data
Elise Koch, Sophie Smart, Guðmundur Einarsson, et al.
Journal of Clinical Oncology : Official Journal of the American Society of Clinical Oncology
|
January 9, 2026
Three Versus 6 Months of Adjuvant Oxaliplatin-Fluoropyrimidine Chemotherapy for Colorectal Cancer: Final Results of SCOT-An International, Randomized, Phase III, Noninferiority Trial
Timothy Iveson, Mark P Saunders, Caroline Kelly, et al.
JAMA Surgery
|
June 12, 2024
Time From Colorectal Cancer Surgery to Adjuvant Chemotherapy: Post Hoc Analysis of the SCOT Randomized Clinical Trial
Mikail Gögenur, Andreas Weinberger Rosen, Timothy Iveson, et al.
Page
of 58